AU7482696A - Methods for administration of il-12 - Google Patents

Methods for administration of il-12

Info

Publication number
AU7482696A
AU7482696A AU74826/96A AU7482696A AU7482696A AU 7482696 A AU7482696 A AU 7482696A AU 74826/96 A AU74826/96 A AU 74826/96A AU 7482696 A AU7482696 A AU 7482696A AU 7482696 A AU7482696 A AU 7482696A
Authority
AU
Australia
Prior art keywords
administration
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU74826/96A
Inventor
Michael F. Debruin
Marc Garnick
Matthew L. Sherman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genetics Institute LLC
Original Assignee
Genetics Institute LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetics Institute LLC filed Critical Genetics Institute LLC
Publication of AU7482696A publication Critical patent/AU7482696A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/208—IL-12

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU74826/96A 1995-11-01 1996-10-30 Methods for administration of il-12 Abandoned AU7482696A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US55162395A 1995-11-01 1995-11-01
US551623 1995-11-01
PCT/US1996/017348 WO1997016203A1 (en) 1995-11-01 1996-10-30 Methods for administration of il-12

Publications (1)

Publication Number Publication Date
AU7482696A true AU7482696A (en) 1997-05-22

Family

ID=24202023

Family Applications (1)

Application Number Title Priority Date Filing Date
AU74826/96A Abandoned AU7482696A (en) 1995-11-01 1996-10-30 Methods for administration of il-12

Country Status (2)

Country Link
AU (1) AU7482696A (en)
WO (1) WO1997016203A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6509313B1 (en) * 1996-02-28 2003-01-21 Cornell Research Foundation, Inc. Stimulation of immune response with low doses of cytokines
EP1030680A4 (en) * 1998-09-15 2003-05-02 Genetics Inst Treatment of kaposi's sarcoma with il-12
EP1066834A3 (en) * 1999-07-08 2004-06-02 Thomas Dr. Stief Pharmaceutical compositions comprising a phagocyte-modulating agent
EP2736530B1 (en) * 2011-07-27 2018-06-06 Neumedicines, Inc Use of il-12 to generate endogenous erythropoietin
RU2014120694A (en) 2011-10-27 2015-12-10 Нкт Терапьютикс Инк. HUMANIZED ANTIBODIES TO iNKT
US20160022777A1 (en) * 2014-07-28 2016-01-28 Nkt Therapeutics Inc. Combination therapy with il-12
EP3655016A1 (en) * 2017-07-17 2020-05-27 CHU de Nantes - Centre Hospitalier Universitaire de Nantes Interleukin 12 (il12) or derivative thereof for use in the treatment of secondary disease
WO2024097767A1 (en) * 2022-11-02 2024-05-10 Sonnet BioTherapeutics, Inc. Recombinant il-12 albumin binding domain fusion proteins for use in methods for the treatment of cancer

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5573764A (en) * 1994-01-21 1996-11-12 Genetics Institute, Inc. Use of interleukin-12 to prevent graft versus host disease

Also Published As

Publication number Publication date
WO1997016203A1 (en) 1997-05-09

Similar Documents

Publication Publication Date Title
AU5268696A (en) Novel compounds and methods for therapy
AUPN698495A0 (en) Improved therapeutic formulation and method
AU6898996A (en) Compositions and methods for growth promotion
AU7572196A (en) Pharmaceutical formulations
AU4926493A (en) Dental implant method
AU1771195A (en) Method of administering azithromycin
AU7608596A (en) Improved high chair system
AU6475996A (en) Wall form structure and methods for their manufacture
AU5886196A (en) Novel benzopyran compounds and methods for their use
AUPN271295A0 (en) Method of treatment
AU7590096A (en) Drug composition
AU5486596A (en) Surgical method
AU6517396A (en) Preparation of N-substituted 3-hydroxypyrazoles
AU6043096A (en) Methods for minimizing bone loss
AU5631096A (en) Antihistamine-wound healing compositions and methods for pre paring and using same
AU5101798A (en) Method for oral administration of buspirone
AU7482696A (en) Methods for administration of il-12
AU1152897A (en) Preparation method of physiologically active compound
AU4877196A (en) Derivatives of 3-pyrrolidylidene-2-one-cephalosporines
AU4325397A (en) Method of omeprazole preparation
AU4939296A (en) Method of reducing prolonged coagulation time
AU5486396A (en) Process for the preparation of spiroindolines
AU7096496A (en) Process for the preparation of 4-methylenepiperidines
AU5347996A (en) Preparation for oral administration
AU6257796A (en) Composition and method for administration of bio-affecting c atalysts